Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18646InvestigationalGene Therapies
Divesiran is a synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues.
- Mechanism
- Curator reviewed
Pharmacologically active on Transmembrane protease serine 6
- Code names
- SLN-124
Resolves to
Compound
Targets
What you can answer from here — as of October 05, 2026
Which drugs share a target with Divesiran, and which of those have an active Phase 3 trial?